Evaluation of Patients With Known or Suspected Heart Disease
Launched by NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (NHLBI) · Nov 3, 1999
Trial Information
Current as of January 15, 2025
Completed
Keywords
ClinConnect Summary
The principal mission of the NIH is the conduct of research that elucidates biological mechanisms, pathogenesis, and treatment of disease. Patients with known or suspected cardiovascular diseases are referred to NHLBI cardiologists for consideration of participation in clinical research protocols. However, eligibility for participation is often uncertain from referral information or even after an outpatient evaluation. The purpose of this protocol is to permit inpatient evaluation of patients for whom participation in clinical research protocols is under consideration in order to determine ...
Gender
ALL
Eligibility criteria
- * INCLUSION CRITERIA:
- The following is a representative list of the types of patient presentations and potential diagnoses eligible for this protocol:
- • 1. Coronary artery disease with angina or inducible myocardial ischemia as determined by noninvasive testing.
- • 2. Cardiomyopathies including congestive phenotypes.
- • 3. Peripheral artery disease with intermittent claudication or limb-threatening ischemia.
- • 4. Renovascular disease with uncontrolled hypertension, intermittent pulmonary edema, or evidence of ischemic nephropathy.
- • 5. Upper extremity peripheral artery disease.
- • 6. Diabetes with heart failure.
- • 7. Pulmonary hypertension.
- EXCLUSION CRITERIA:
- • Pregnancy, for those patients who require catheterization-based diagnostics.
- • Inability to provide informed consent.
About National Heart, Lung, And Blood Institute (Nhlbi)
The National Heart, Lung, and Blood Institute (NHLBI) is a leading component of the National Institutes of Health (NIH), dedicated to advancing research and clinical trials focused on cardiovascular, pulmonary, and hematologic diseases. With a mission to improve public health through innovative research, the NHLBI supports a wide range of studies aimed at understanding, preventing, and treating heart and lung conditions. By collaborating with academic institutions, healthcare providers, and patient communities, the NHLBI strives to translate scientific discoveries into effective clinical practices, ultimately enhancing the quality of life for individuals affected by these critical health issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethesda, Maryland, United States
Bethesda, Maryland, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials